| Article | Date | Source |
|---|
| Alnylam Discusses RNAi Delivery | -- | Outsourcing - BioPharm |
| Alnylam Pharmaceuticals (ALNY) Reports Second Quarter | -- | Biotechnology - Moreover |
| Alnylam and PBL Sign License Agreement for Baulcombe & Hamilton RNAi Patent | May 23, 2012 | Pharma News - Business Wire |
| Tekmira Pharmaceuticals Corporation's LNP Technology Enables Alnylam Pharmaceuticals's ALN-TTR01 Clinical Data | May 10, 2012 | BioSpace - Breaking News |
| Alnylam Presents Final Results from a Phase I Clinical Trial of ALN-TTR01, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of Transthyretin-Mediated Amyloidosis (ATTR) | May 10, 2012 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Reports First Quarter 2012 Financial Results | May 03, 2012 | Pharma News - Business Wire |
| Alnylam Elects Dr. Dennis Ausiello to its Board of Directors and Scientific Advisory Board | April 23, 2012 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals to Webcast Presentation at Conference | April 16, 2012 | BioSpace - Breaking News |
| Alnylam to Webcast Presentation at Future Leaders in the Biotech Industry Conference | April 13, 2012 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Phase I Clinical Study of ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR) | March 19, 2012 | BioSpace - Breaking News |
| Alnylam Initiates Phase I Clinical Study of ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR) | March 19, 2012 | Pharma News - Business Wire |
| Alnylam Retains Key Claims for Kinesin Spindle Protein (KSP) RNAi Patent in Interference Proceedings | March 14, 2012 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at Barclays Capital Global Healthcare Conference | March 06, 2012 | Pharma News - Business Wire |
| Alnylam and the University of Massachusetts Medical School Announce Tuschl I Patent Upheld in European Opposition Proceedings | March 01, 2012 | Pharma News - Business Wire |
| A Forward Look, the Year Ahead - Featured Research on Alnylam Pharmaceuticals, Inc. and ISIS Pharmaceuticals, Inc. | February 17, 2012 | Marketwire - Pharma and Biotech |
| Alnylam identifies who's getting ax | February 16, 2012 | FierceBiotech |
| Alnylam Pharmaceuticals Prices Public Offering of Common Stock | February 15, 2012 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Announces Proposed Public Offering of Common Stock | February 13, 2012 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals to Webcast Presentations at Upcoming Investor Conferences | February 13, 2012 | BioSpace - Breaking News |
| Alnylam Scientists Discover Novel Method for Monitoring RNAi Activity in Blood Samples | February 09, 2012 | Pharma News - Business Wire |
| Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2011 Financial Results | February 02, 2012 | Pharma News - Business Wire |
| Alnylam Receives Notice of Allowance from United States Patent and Trademark Office (USPTO) for New Patent Broadly Covering Second Generation Lipid Nanoparticles (LNP) for Systemic Delivery of RNAi Therapeutics | January 30, 2012 | Pharma News - Business Wire |
| MASS. MOVERS: Alnylam rises after restructuring news | January 24, 2012 | Biotechnology - Moreover |
| Alnylam Pharmaceuticals to Shed a Third of Its Work Force
| January 20, 2012 | BioSpace |
| Alnylam Restructures, Cuts 33% of Workforce | January 20, 2012 | Contract Pharma |
| Alnylam cutting third of jobs to devote cash to lead RNAi programs | January 20, 2012 | FierceBiotech |
| Cambridge biotech Alnylam to lay off one third of workers | January 20, 2012 | Health News - BizJournals.com |
| Alnylam Cuts One-Third of Workforce, To Save Cash for RNAi Clinical Plans | January 19, 2012 | Xconomy Life Sciences |
| Alnylam to Restructure Organization, Aligning Resources with Focus on Highest Value Pipeline Opportunities in “Alnylam 5x15™” Product Strategy | January 19, 2012 | Pharma News - Business Wire |
| Alnylam Claims Tekmira Infringed RNAi Tech Patents | January 19, 2012 | Pharmaceutical - Moreover |
| Alnylam Pharmaceuticals (ALNY) Files Patent Infringement Suit Against Tekmira Pharmaceuticals Corporation | January 18, 2012 | Pharmaceutical - Moreover |
| Tekmira sued by Alnylam for patent infringement | January 17, 2012 | Pharmaceutical - Moreover |
| Alnylam Pharmaceuticals Files Patent Infringement Suit Against Tekmira Pharmaceuticals Corporation | January 17, 2012 | Pharmaceutical - Moreover |
| Alnylam Files Patent Infringement Suit Against Tekmira | January 17, 2012 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Files Clinical Trial Application for ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidosis | January 06, 2012 | BioSpace - Breaking News |
| Alnylam Files Clinical Trial Application for ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidosis | January 06, 2012 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals and Arrowhead Research Corporation Form Collaboration and Licensing Agreement | January 05, 2012 | BioSpace - Breaking News |
| Alnylam and Arrowhead Form Collaboration and Licensing Agreement | January 05, 2012 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at 30th Annual J.P. Morgan Healthcare Conference 2012 | January 04, 2012 | Pharma News - Business Wire |
| Will Alnylam's Prospective Obesity Drug Change the World Forever? | January 04, 2012 | Pharmaceutical - Moreover |
| Alnylam Pharmaceuticals Reports Positive Preliminary Clinical Results for ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia | January 04, 2012 | BioSpace - Breaking News |
| Countering skeptics, Alnylam claims pioneering first in RNAi cholesterol study | January 04, 2012 | FierceBiotech |
| Alnylam's drug reduces bad cholesterol in early study | January 04, 2012 | Health News - CNBC |
| Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug | January 04, 2012 | Xconomy Life Sciences |
| Alnylam Reports Positive Preliminary Clinical Results for ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia | January 04, 2012 | Pharma News - Business Wire |
| Alnylam Announces Publication of Pre-clinical Results with ALN-HTT, an RNAi Therapeutic for the Treatment of Huntington’s Disease, in Experimental Neurology | December 28, 2011 | Pharma News - Business Wire |
| Alnylam Scientists Present New Data on RNAi Therapeutics at 53rd ASH Annual Meeting | December 13, 2011 | Pharma News - Business Wire |
| Alnylam Racing to Prove RNAi Works, For a Disease You’ve Never Heard Of | December 13, 2011 | Xconomy Life Sciences |
| Alnylam Pharmaceuticals Completes Enrollment in Phase IIb Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
| November 29, 2011 | BioSpace - Breaking News |
| Alnylam Completes Enrollment in Phase IIb Study of ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection | November 29, 2011 | Pharma News - Business Wire |
| Will Alnylam's Results Reignite Fervor for RNAi | November 23, 2011 | Burrill Report |
| Alnylam to Webcast Presentation at the Piper Jaffray 23rd Annual Health Care Conference | November 22, 2011 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Presents Positive Preliminary Clinical Results for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis | November 21, 2011 | BioSpace - Breaking News |
| Alnylam Presents Positive Preliminary Clinical Results for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis | November 21, 2011 | Pharma News - Business Wire |
| Alnylam grants Zeltia non-exclusive licence option for InterfeRx | November 17, 2011 | Pharmaceutical - Moreover |
| Alnylam Pharmaceuticals Grants InterfeRx™ Intellectual Property License to Sylentis for Development and Commercialization of RNAi Therapeutics | November 16, 2011 | Pharma News - Business Wire |
| Alnylam to Present Phase I Clinical Data at VIIIth International Symposium on Familial Amyloidotic Polyneuropathy | November 15, 2011 | Pharma News - Business Wire |
| Langer Nabs Cash From Rock Stars, Verastem Seeks $50M IPO, Alnylam Snags RNAi Collab, & More Boston-Area Life Sciences News | November 04, 2011 | Xconomy Life Sciences |
| GSK taps Alnylam tech for faster vaccine production | November 03, 2011 | FierceVaccines |
| Repligen Buys Novozymes Unit, World Energy Acquires GSE Consulting, Alnylam Partners With GSK, & More Boston-Area Deals News | November 02, 2011 | Xconomy Life Sciences |
| GSK, Alnylam team to speed vaccine production | November 01, 2011 | FiercePharma Manufacturing |
| Alnylam Pharmaceuticals Reports Third Quarter 2011 Financial Results | November 01, 2011 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals and GlaxoSmithKline Form Collaboration on RNAi Technology for Vaccine Production | November 01, 2011 | BioSpace - Breaking News |
| GlaxoSmithKline Taps Alnylam Pharmaceuticals's RNAi Technology for Vaccine Production | November 01, 2011 | BioSpace |
| Alnylam and Glaxo Partner on RNAi for Vaccine Production | November 01, 2011 | Xconomy Life Sciences |
| Alnylam and GlaxoSmithKline Form Collaboration on RNAi Technology for Vaccine Production | November 01, 2011 | Pharma News - Business Wire |
| Alnylam to Webcast Conference Call Discussing Third Quarter 2011 Financial Results | October 25, 2011 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at the Newsmakers in the Biotech Industry 2011 Conference | October 20, 2011 | Pharma News - Business Wire |
| Alnylam and Collaborators Publish New Pre-clinical Data on Delivery of RNAi Therapeutics to Key Cell Types Regulating Immune and Inflammatory Diseases | October 11, 2011 | Pharma News - Business Wire |
| Alnylam Initiates Phase I Clinical Study of ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia | September 26, 2011 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at the JMP Securities Healthcare Conference | September 21, 2011 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals (ALNY) Scientists and Collaborators Report Significant New Advances in Delivery of RNAi Therapeutics at 20 | September 13, 2011 | Biotechnology - Moreover |
| Alnylam to Webcast Presentation at the UBS Global Life Sciences Conference | September 12, 2011 | Pharma News - Business Wire |
| Alnylam Scientists and Collaborators Report Significant New Advances in Delivery of RNAi Therapeutics at 2011 Oligonucleotides Therapeutics Society Meeting | September 12, 2011 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Expands "Alnylam 5x15" RNAi Therapeutic Pipeline with ALN-APC, an RNAi Therapeutic Targeting Protein C for the Treatment of Hemophilia
| September 08, 2011 | BioSpace - Breaking News |
| Alnylam Expands “Alnylam 5x15” RNAi Therapeutic Pipeline with ALN-APC, an RNAi Therapeutic Targeting Protein C for the Treatment of Hemophilia | September 08, 2011 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at Upcoming Investor Conferences | September 07, 2011 | Pharma News - Business Wire |
| Alnylam narrows loss on lower costs | August 02, 2011 | Health News - BizJournals.com |
| Alnylam Pharmaceuticals Reports Second Quarter 2011 Financial Results | August 01, 2011 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Completes ALN-VSP Phase I Trial in Patients with Liver Cancer | August 01, 2011 | BioSpace - Breaking News |
| Alnylam Completes ALN-VSP Phase I Trial in Patients with Liver Cancer | August 01, 2011 | Pharma News - Business Wire |
| Alnylam to Webcast Conference Call Discussing Second Quarter 2011 Financial Results | July 25, 2011 | Pharma News - Business Wire |
| Alnylam and MIT Collaborators Discover Novel “Core-Shell” Nanoparticles for Systemic Delivery of RNAi Therapeutics | July 25, 2011 | Pharma News - Business Wire |
| Alnylam and MIT Collaborators Publish Data on Novel Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics | July 19, 2011 | Pharma News - Business Wire |
| McNicoll, Lewis & Vlak Reiterates Alnylam Pharmaceuticals Buy, $15 PT | July 11, 2011 | Biotechnology - Moreover |
| Alnylam Files Clinical Trial Application (CTA) for ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia | July 11, 2011 | Pharma News - Business Wire |
| Alnylam Presents New Data from ALN-TTR Program at Peripheral Nerve Society Meeting | June 28, 2011 | Pharma News - Business Wire |
| Alnylam Scientists and Collaborators Publish New Article in Nature Describing Discovery of Central Gene in Mitochondrial Physiology | June 19, 2011 | Pharma News - Business Wire |
| Alnylam and Spectrum both name new chief medical officers | June 14, 2011 | Biotechnology - Moreover |
| Alnylam Appoints Akshay Vaishnaw as Chief Medical Officer | June 13, 2011 | Pharma News - Business Wire |
| Alnylam chief scientific officer jumps ship | June 08, 2011 | Health News - BizJournals.com |
| Alnylam Pharmaceuticals Chief Scientific Officer to Leave Company | June 08, 2011 | BioSpace |
| Alnylam Provides Organizational Update | June 07, 2011 | Pharma News - Business Wire |
| Alnylam Presents Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting | June 04, 2011 | Pharma News - Business Wire |
| Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News | May 27, 2011 | Xconomy Life Sciences |
| Alnylam Pharmaceuticals Looks to Shine at American Society of Clinical Oncology, Plans for a RNAi Resurgence | May 27, 2011 | BioSpace |
| Alnylam Pharmaceuticals Looks to American Society of Clinical Oncology as First ???Bell-Ringing??? for RNAi Resurgence | May 27, 2011 | BioSpace |
| Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence | May 26, 2011 | Xconomy Life Sciences |
| Alnylam to Webcast Presentation at ThinkEquity’s 2nd Annual Health Care Conference: A Mid Year Checkup | May 20, 2011 | Biotech News - Business Wire |
| Alnylam to Webcast Presentation at 2011 Bank of America Merrill Lynch Health Care Conference | May 04, 2011 | Pharma News - Business Wire |
| Molecular Templates Inc. Announces RNAi Drug-Delivery Research Collaboration with Alnylam Pharmaceuticals | May 04, 2011 | BioSpace |
| Molecular Templates Announces RNAi Drug-Delivery Research Collaboration with Alnylam Pharmaceuticals | May 04, 2011 | Pharma News - Business Wire |
| Alnylam's Q1 loss grows | May 02, 2011 | Health News - BizJournals.com |
| Alnylam Pharmaceuticals Reports First Quarter 2011 Financial Results | May 02, 2011 | Pharma News - Business Wire |
| Alnylam to Webcast Conference Call Discussing First Quarter 2011 Financial Results | April 27, 2011 | Pharma News - Business Wire |
| Alnylam inks research deal | April 20, 2011 | Health News - BizJournals.com |
| Amid Delivery Tech Dispute, Alnylam Forges Collaboration with Precision NanoSystems | April 19, 2011 | Pharmaceutical - Moreover |
| Alnylam Inks Deal with Precision NanoSystems | April 19, 2011 | Xconomy Life Sciences |
| Precision NanoSystems and Alnylam Form New Delivery Collaboration | April 19, 2011 | Pharma News - Business Wire |
| AlCana Technologies, The University of British Columbia, and Alnylam Extend Delivery Research Collaboration | April 07, 2011 | Pharma News - Business Wire |
| Alnylam Responds to Tekmira Suit | April 06, 2011 | Xconomy Life Sciences |
| Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit | April 06, 2011 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals (ALNY) to Webcast Presentation at | April 01, 2011 | Biotechnology - Moreover |
| Alnylam Completes Enrollment in ALN-VSP Phase I Clinical Trial | March 31, 2011 | Pharma News - Business Wire |
| Takeda Makes Alnylam $10M | March 30, 2011 | Pharmaceutical - Moreover |
| Alnylam to Webcast Presentation at 10th Annual Needham Healthcare Conference | March 30, 2011 | Pharma News - Business Wire |
| Alnylam earns $10 million from Takeda alliance | March 29, 2011 | Pharmaceutical - Moreover |
| Alnylam lands $10M from Japan's Takeda | March 28, 2011 | Health News - BizJournals.com |
| Alnylam lands $10M pay from Takeda | March 28, 2011 | Pharmaceutical - Moreover |
| Alnylam Pharma gets $10M payment from Takeda | March 28, 2011 | Health News - CNBC |
| Alnylam Pharmaceuticals Achieves Key Technology Transfer Objective in its Takeda Pharmaceutical Co. Ltd. Alliance; Earns $10 Million Payment | March 28, 2011 | BioSpace |
| Alnylam Achieves Key Technology Transfer Objective in its Takeda Alliance; Earns $10 Million Payment | March 28, 2011 | Pharma News - Business Wire |
| Alnylam Sued By Tekmira, Curis Cancer Drug Shows Results, Still River Gets $11.5M, & More Boston-Area Life Sciences News | March 25, 2011 | Xconomy Life Sciences |
| SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News | March 24, 2011 | Xconomy Life Sciences |
| Alnylam Named in Complaint Over RNAi Patents | March 23, 2011 | Xconomy Life Sciences |
| Alnylam CEO: Tekmira Accusation of Trade Secret Misuse was a “Big Surprise” | March 18, 2011 | Xconomy Life Sciences |
| Tekmira-Alnylam Lawsuit Centers on Drug Carrier Particles | March 18, 2011 | Xconomy Life Sciences |
| Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News | March 18, 2011 | Xconomy Life Sciences |
| Alnylam dismisses Tekmira IP lawsuit | March 17, 2011 | Biotechnology - Moreover |
| Tekmira Pharmaceuticals Corporation Sues Alnylam Pharmaceuticals for $1 Billion, Accusing Partner of Misusing RNAi Trade Secrets | March 17, 2011 | BioSpace - Breaking News |
| Alnylam fires back after Tekmira lawsuit | March 17, 2011 | Health News - BizJournals.com |
| Alnylam Responds to Tekmira Complaint | March 17, 2011 | Pharma News - Business Wire |
| Tekmira Sues Alnylam for $1 Billion, Accusing Partner of Misusing RNAi Trade Secrets | March 16, 2011 | Xconomy Life Sciences |
| Alnylam et al resolve a fight over RNAi rights | March 16, 2011 | FierceBiotech |
| Alnylam Pharmaceuticals Reaches Settlement in Litigation Regarding Tuschl Patents | March 15, 2011 | Pharma News - Business Wire |
| Alnylam Announces Management Transition in Finance | March 03, 2011 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at 31st Annual Cowen and Company Health Care Conference | March 02, 2011 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals (ALNY) Reports Fourth Quarter and 20 | February 19, 2011 | Biotechnology - Moreover |
| Alnylam Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results | February 17, 2011 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals (ALNY) to Webcast Conference Call Discussing Fourth Quarter and 20 | February 12, 2011 | Biotechnology - Moreover |
| Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2010 Financial Results | February 10, 2011 | Pharma News - Business Wire |
| Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011 | February 07, 2011 | Xconomy Life Sciences |
| Alnylam Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation from European Medicines Evaluation Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis | January 25, 2011 | BioSpace - Breaking News |
| Alnylam Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis | January 25, 2011 | Pharma News - Business Wire |
| Alnylam banks on new technology for rebound | January 14, 2011 | Health News - BizJournals.com |
| Alnylam Pharmaceuticals (ALNY) Launches “Alnylam 5x15” Product Strategy and Provides Guidance and Goals for | January 07, 2011 | Biotechnology - Moreover |
| Alnylam Lays Out 2015 Goals | January 06, 2011 | Xconomy Life Sciences |
| Alnylam Launches “Alnylam 5x15” Product Strategy and Provides Guidance and Goals for 2011 | January 06, 2011 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at the 29th Annual J.P. Morgan Healthcare Conference | January 05, 2011 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Demonstrates RNAi in Man with Systemically Delivered RNAi Therapeutics | January 04, 2011 | BioSpace - Breaking News |
| Alnylam Demonstrates RNAi in Man with Systemically Delivered RNAi Therapeutics | January 04, 2011 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals (ALNY) and Medtronic, Inc. (MDT)'s Joint Project to Block Gene in Huntington's | December 28, 2010 | Biotechnology - Moreover |
| Alnylam Pharmaceuticals and Medtronic, Inc.'s Joint Project to Block Gene in Huntington's | December 28, 2010 | BioSpace |
| Alnylam Pharmaceuticals Presents New Data on Delivery of RNAi Therapeutics and Human Translation | December 16, 2010 | BioSpace - Breaking News |
| Alnylam Presents New Data on Delivery of RNAi Therapeutics and Human Translation | December 16, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals appoints new board member | December 10, 2010 | Pharmaceutical - Moreover |
| Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News | December 10, 2010 | Xconomy Life Sciences |
| Alnylam elects Fanucci to board | December 09, 2010 | Biotechnology - Moreover |
| Alnylam Elects Marsha Fanucci to its Board of Directors | December 09, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at 2010 Deutsche Bank BioFEST | December 08, 2010 | Pharma News - Business Wire |
| Alnylam CEO John Maraganore On Corporate Near-Termism, and Restoring Faith in RNAi | December 06, 2010 | Xconomy Life Sciences |
| Alnylam says it won Europe RNA patent dispute | December 02, 2010 | Health News - CNBC |
| Alnylam to Webcast Presentation at Piper Jaffray 22nd Annual Healthcare Conference | November 23, 2010 | Pharma News - Business Wire |
| Roche Drops Alnylam Alliance | November 19, 2010 | Burrill Report |
| Alnylam Biotherapeutics Presents Data on New Applications of RNAi Technology for Biologics Manufacturing | November 18, 2010 | Pharma News - Business Wire |
| Alnylam Comments on Recent Roche Restructuring and Implications for RNAi Therapeutics | November 17, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at Lazard Capital Markets 7th Annual Healthcare Conference | November 11, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Presents Additional Interim Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer | November 11, 2010 | BioSpace - Breaking News |
| Tekmira Partner Alnylam Presents Additional ALN-VSP Interim Phase 1 Clinical Trial Data at the Chemotherapy Foundation Symposium | November 10, 2010 | Marketwire - Pharma and Biotech |
| Alnylam Presents Additional Interim Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer | November 10, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals, Medtronic, Inc. & CHDI, Inc. Form RNAi Delivery Collaboration | November 08, 2010 | BioSpace |
| Medtronic Joins With Alnylam to Treat Huntington’s Disease | November 04, 2010 | Pharmaceutical - Moreover |
| Alnylam licenses Ebola drug technology to Tekmira | November 04, 2010 | Health News - CNBC |
| Tekmira Nabs License to Alnylam IP to Develop Ebola Virus Therapy Funded by U.S. Govt | November 04, 2010 | Inside Industry - Gen |
| Tekmira Nabs License to Alnylam IP to Develop Ebola Virus Therapy Funded by U.S. Govt. | November 04, 2010 | Inside Industry - Gen |
| Alnylam Grants New InterfeRx(TM) Intellectual Property License to Tekmira for Development and Commercialization of TKM-Ebola, an RNAi Therapeutic for the Treatment of Ebola Virus Infection | November 04, 2010 | Marketwire - Pharma and Biotech |
| Alnylam Grants New InterfeRxTM Intellectual Property License to Tekmira for Development and Commercialization of TKM-Ebola, an RNAi Therapeutic for the Treatment of Ebola Virus Infection | November 04, 2010 | Pharma News - Business Wire |
| Alnylam takes wider 3Q loss as testing costs grow | November 03, 2010 | Health News - CNBC |
| Alnylam Pharmaceuticals Reports Third Quarter 2010 Financial Results | November 03, 2010 | Pharma News - Business Wire |
| Alnylam and Medtronic working with CHDI Foundation | November 03, 2010 | Health News - CNBC |
| Alnylam Pharmaceuticals Scientists to Present New Data on RNAi Therapeutics at the 61st Annual Meeting of the | October 29, 2010 | BioSpace - Breaking News |
| Alnylam Scientists to Present New Data on RNAi Therapeutics at the 61st Annual Meeting of the American Association for the Study of Liver Diseases | October 29, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Conference Call Discussing Third Quarter 2010 Financial Results | October 27, 2010 | Pharma News - Business Wire |
| Alnylam Seeks to Prove RNAi Skeptics Wrong After Layoffs, End of Novartis Deal | October 21, 2010 | Xconomy Life Sciences |
| Alnylam Scientists Present New Research on Expanded Delivery of RNAi Therapeutics | October 08, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Publishes Results from Phase IIa Study of ALN-RSV01 in the Treatment of Respiratory Syncytial Virus Infection in Lung Transplant Patients | September 29, 2010 | BioSpace - Breaking News |
| Alnylam Publishes Results from Phase IIa Study of ALN-RSV01 in the Treatment of Respiratory Syncytial Virus Infection in Lung Transplant Patients | September 29, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals to Cut 20-30 Pct Jobs After Novartis AG Ends Partnership | September 24, 2010 | BioSpace - Breaking News |
| Novartis deal over, Alnylam cuts staff | September 24, 2010 | Health News - BizJournals.com |
| Alnylam to Nix Jobs in the Wake of Novartis Collaboration Ending | September 24, 2010 | Inside Industry - Gen |
| Alnylam announces 25-30% reduction of workforce | September 24, 2010 | FierceBiotech |
| Alnylam Pharma to cut up to 30 pct of work force | September 24, 2010 | Health News - CNBC |
| Alnylam Pharma To Cut 25%-30% Of Work Force As Alliance Ends | September 23, 2010 | Health News - Fox Business |
| Alnylam Cuts 25-30% of Workforce, As Novartis Alliance Ends | September 23, 2010 | Xconomy Life Sciences |
| Alnylam Provides Update on Novartis Collaboration, Announces Corporate Restructuring, and Reaffirms Financial Guidance for 2010 | September 23, 2010 | Pharma News - Business Wire |
| Alnylam elects former Lilly researcher to board | September 23, 2010 | Health News - CNBC |
| Alnylam Announces Update on its Board of Directors | September 22, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals to Webcast Presentation at Global Life Sciences Conference | September 15, 2010 | BioSpace - Breaking News |
| Alnylam to Webcast Presentation at UBS Global Life Sciences Conference | September 14, 2010 | Pharma News - Business Wire |
| Alnylam Scientists Present New Data on RNAi Therapeutics at American Chemical Society (ACS) 2010 National Meeting | August 24, 2010 | Pharma News - Business Wire |
| Alnylam advances Parkinson's research | August 23, 2010 | Health News - BizJournals.com |
| Alnylam Pharmaceuticals and Collaborators Publish New Pre-clinical Research on Therapeutic Silencing of Parkinson's Disease Gene | August 23, 2010 | BioSpace - Breaking News |
| Alnylam and Collaborators Publish New Pre-clinical Research on Therapeutic Silencing of Parkinson’s Disease Gene | August 23, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Release: Medicines for Malaria Venture (MMV) Becomes First Product Development Partnership to Contribute Patents to the Pool for Open Innovation against Neglected Tropical Diseases | August 16, 2010 | BioSpace - Breaking News |
| Alnylam Pharmaceuticals Scientists and Collaborators Report Significant New Advances in RNAi Delivery | August 09, 2010 | BioSpace - Breaking News |
| Alnylam Scientists and Collaborators Report Significant New Advances in RNAi Delivery | August 09, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Scientists Contribute to Discovery of a New Disease Gene in Cardiovascular Disease | August 05, 2010 | BioSpace - Breaking News |
| Alnylam Scientists Contribute to Discovery of a New Disease Gene in Cardiovascular Disease | August 05, 2010 | Pharma News - Business Wire |
| Alnylam takes smaller 2Q loss, cuts research costs | August 04, 2010 | Health News - CNBC |
| Alnylam Pharmaceuticals Reports Second Quarter 2010 Financial Results | August 04, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Conference Call Discussing Second Quarter 2010 Financial Results | July 28, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals to Webcast Virtual RNAi Roundtable on ALN-TTR for Treatment of Transthyretin-Mediated Amyloidosis | July 20, 2010 | BioSpace - Breaking News |
| Alnylam to Webcast Virtual RNAi Roundtable on ALN-TTR for Treatment of Transthyretin-Mediated Amyloidosis | July 19, 2010 | Pharma News - Business Wire |
| Tekmira Pharmaceuticals Corporation's Partner Alnylam Pharmaceuticals Initiates Dosing in a Phase 1 Clinical Trial of ALN-TTR01 | July 07, 2010 | BioSpace - Breaking News |
| Alnylam launches rare-disease trial | July 07, 2010 | Health News - BizJournals.com |
| Alnylam Pharmaceuticals Initiates Dosing in Phase I Clinical Study of ALN-TTR01 in Patients with Transthyretin-Mediated Amyloidosis (ATTR) | July 07, 2010 | BioSpace - Breaking News |
| Tekmira's Partner Alnylam Initiates Dosing in a Phase 1 Clinical Trial of ALN-TTR01 | July 07, 2010 | Marketwire - Pharma and Biotech |
| Alnylam Initiates Dosing in Phase I Clinical Study of ALN-TTR01 in Patients with Transthyretin-Mediated Amyloidosis (ATTR) | July 07, 2010 | Pharma News - Business Wire |
| Alnylam receives OK for early stage drug testing | June 29, 2010 | Health News - CNBC |
| Alnylam Pharmaceuticals Obtains Approvals to Initiate Phase I Study with ALN-TTR01 in Patients with TTR-Mediated Amyloidosis (ATTR) | June 29, 2010 | BioSpace - Breaking News |
| Alnylam Obtains Approvals to Initiate Phase I Study with ALN-TTR01 in Patients with TTR-Mediated Amyloidosis (ATTR) | June 29, 2010 | Pharma News - Business Wire |
| Alnylam Scientists and Collaborators Publish Research in Nature Chemical Biology on a Novel Mechanism for Regulation of Gene Expression with Anti-Gene RNAs (agRNAs) | June 28, 2010 | Pharma News - Business Wire |
| Third Rock Invests in Ablexis, Acceleron Grabs $8.4M, Alnylam Chief Joins Agios Board, & More Boston-Area Life Sciences News | June 25, 2010 | Xconomy Life Sciences |
| Agios Adds Alnylam Chief to Board | June 24, 2010 | Xconomy Life Sciences |
| Alnylam Pharmaceuticals Presents New Data on RNAi Applications in Biotherapeutics Manufacturing | June 23, 2010 | BioSpace - Breaking News |
| Alnylam Biotherapeutics Presents New Data on RNAi Applications in Biotherapeutics Manufacturing | June 23, 2010 | Pharma News - Business Wire |
| Alnylam moves higher on venture deal | June 23, 2010 | Pharmaceutical - Moreover |
| Isis and Alnylam Provide Update on Regulus’ Strategic Alliance with Sanofi-Aventis | June 22, 2010 | Pharma News - Business Wire |
| Alnylam Secures Intellectual Property and Technology for RNAi Applications in Vaccine Research and Development | June 17, 2010 | Pharma News - Business Wire |
| Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics that Target Mutated Genes | June 17, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at the 5th Annual Piper Jaffray Europe Conference | June 16, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at the 9th Annual Needham Healthcare Conference | June 07, 2010 | Pharma News - Business Wire |
| Tekmira Partner Alnylam Presents ALN-VSP Preliminary Phase 1 Clinical Trial Results at American Society of Clinical Oncology (ASCO) Annual Meeting | June 07, 2010 | Marketwire - Pharma and Biotech |
| Alnylam Presents Preliminary Phase I Data at American Society of Clinical Oncology (ASCO) Meeting for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers | June 07, 2010 | Pharma News - Business Wire |
| Alnylam Biotherapeutics Forms Scientific Advisory Board | June 03, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Presentations at Upcoming Investor Conferences | June 02, 2010 | Pharma News - Business Wire |
| Alnylam Strengthens Management Team with New Key Appointments | June 02, 2010 | Pharma News - Business Wire |
| Alnylam and Collaborators Discover New Class of Small RNAs in Flu | June 01, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Presentations at the Rodman & Renshaw 6th Annual Global Healthcare Conference and the Baird 2010 Growth Stock Conference | May 12, 2010 | Pharma News - Business Wire |
| Alnylam Scientists and Collaborators Publish Research on Key Mechanism for Delivery of RNAi Therapeutics with Lipid Nanoparticles (LNPs) | May 11, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Reports First Quarter 2010 Financial Results | May 05, 2010 | Pharma News - Business Wire |
| Alnylam Pharma to receive EU patent approval | May 03, 2010 | Health News - CNBC |
| Alnylam Receives Intent to Grant for New Patent Broadly Covering RNAi Therapeutics | May 03, 2010 | Pharmaceutical - Moreover |
| Alnylam Pharma (ALNY) Announces Receipt of siRNA Patent from EPO | May 03, 2010 | Pharmaceutical - Moreover |
| Alnylam Receives Intent to Grant by European Patent Office for New Patent Broadly Covering RNAi Therapeutics | May 03, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals and Collaborators at Publish Paper on Novel Synthetic Method for Bi-functional 3p-siRNAs | April 30, 2010 | BioSpace - Breaking News |
| Alnylam Pharmaceuticals to Webcast Conference Call Discussing First Quarter 2010 Financial Results | April 30, 2010 | BioSpace - Breaking News |
| Alnylam and Collaborators at CNRS – Université de Montpellier Publish Paper on Novel Synthetic Method for Bi-functional 3p-siRNAs | April 30, 2010 | Pharma News - Business Wire |
| Novartis Buys Alnylam Shares, Xconomy Holds First Ever Health IT Forum, Vertex Alumni Spread Throughout Life Sciences Sector, & More Boston-Area Life Sciences News | April 30, 2010 | Xconomy Life Sciences |
| Alnylam to Webcast Conference Call Discussing First Quarter 2010 Financial Results | April 29, 2010 | Pharma News - Business Wire |
| Alnylam Named to The Scientist Magazine’s 2010 Best Places to Work in Industry | April 29, 2010 | Pharma News - Business Wire |
| Alnylam Biotherapeutics Presents New Results on Use of RNAi Technologies for Biotherapeutics Manufacturing | April 28, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Publishes Results from Phase II GEMINI Trial with ALN-RSV01 | April 27, 2010 | BioSpace - Breaking News |
| Alnylam Pharmaceuticals publishes encouraging results from Phase II GEMINI study in PNAS | April 27, 2010 | Pharmaceutical - Moreover |
| Alnylam Publishes Results from Phase II GEMINI Trial with ALN-RSV01 | April 27, 2010 | Pharma News - Business Wire |
| Novartis adds to its cache of Alnylam shares | April 26, 2010 | FierceBiotech |
| Novartis Corporation Exercises its Right to Purchase Additional Shares of Alnylam Pharmaceuticals Common Stock | April 26, 2010 | BioSpace |
| Novartis buys 55,000 Alnylam Pharma shares | April 26, 2010 | Health News - CNBC |
| Novartis Buys More Alnylam Shares | April 26, 2010 | Xconomy Life Sciences |
| Novartis Exercises its Right to Purchase Additional Shares of Alnylam Common Stock | April 26, 2010 | Pharma News - Business Wire |
| Alnylam and Collaborators Demonstrate Regression of Pathogenic Transthyretin (TTR) Amyloid Deposits Following Treatment with an RNAi Therapeutic in an Animal Model of TTR-Mediated Amyloidosis (ATTR) | April 20, 2010 | Pharma News - Business Wire |
| Alnylam Announces Grant of New United States Patent Broadly Covering RNAi Therapeutics | April 07, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Announces Additional Grant of Tuschl II Patent in Japan | March 31, 2010 | BioSpace - Breaking News |
| Alnylam Announces Additional Grant of Tuschl II Patent in Japan | March 31, 2010 | Pharma News - Business Wire |
| Alnylam Gets $20M Payment - Analyst Blog | March 24, 2010 | Pharmaceutical - Moreover |
| Takeda pays Alnylam $20 million for transfer of RNAi technology | March 24, 2010 | Pharmaceutical - Moreover |
| Novell Turns Down Buyout Offer, Alnylam Pulls In $20M from Takeda, $16M Stock Deal Goes to RXi, & More Boston-Area Deals News | March 24, 2010 | Xconomy Life Sciences |
| Alnylam nets another $20m from Takeda | March 23, 2010 | Health News - BizJournals.com |
| Alnylam Pharmaceuticals Completes Key Technology Transfer Objectives in its Takeda Pharmaceutical Co. Ltd. Alliance and Earns $20 Million Payment | March 23, 2010 | BioSpace |
| Alnylam Gets $20M From Takeda | March 23, 2010 | Xconomy Life Sciences |
| Alnylam Earns Takeda Milestone | March 23, 2010 | Contract Pharma |
| Alnylam gets $20 million payment from Takeda | March 23, 2010 | Health News - CNBC |
| Alnylam Completes Key Technology Transfer Objectives in its Takeda Alliance and Earns $20 Million Payment | March 23, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals and Collaborators Present New Pre-Clinical Research on RNAi Therapeutics Targeting PCSK9
| March 15, 2010 | BioSpace - Breaking News |
| Alnylam and Collaborators Present New Pre-Clinical Research on RNAi Therapeutics Targeting PCSK9 | March 15, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at the 22nd Annual ROTH OC Growth Stock Conference | March 09, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at Cowen and Company’s 30th Annual Health Care Conference | March 03, 2010 | Pharma News - Business Wire |
| Alnylam Provides Update on Ongoing Litigation Regarding the Tuschl I Patent Series | March 02, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast RNAi Roundtable on Thursday, March 4, 2010 | February 26, 2010 | Biotech News - Business Wire |
| Alnylam Pharmaceuticals Reports Fourth Quarter and 2009 Financial Results | February 25, 2010 | Pharma News - Business Wire |
| Alnylam Selected as One of the 50 Most Innovative Companies in the World by MIT’s Technology Review | February 24, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Initiates Phase IIb Clinical Trial of ALN-RSV01 in Adult Lung Transplant Patients Infected with Respiratory Syncytial Virus (RSV) Infection | February 22, 2010 | BioSpace - Breaking News |
| Alnylam Initiates Phase IIb Clinical Trial of ALN-RSV01 in Adult Lung Transplant Patients Infected with Respiratory Syncytial Virus (RSV) Infection | February 22, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results | February 18, 2010 | Biotech News - Business Wire |
| Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics | February 08, 2010 | Pharma News - Business Wire |
| Alnylam to Webcast Presentation at The 12th Annual BIO CEO & Investor Conference | February 01, 2010 | Pharma News - Business Wire |
| Regulus, Alnylam and Isis Announce U.S. Allowance of Tuschl III Patent Application Covering miR-21 | January 25, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposium | January 20, 2010 | BioSpace - Breaking News |
| BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool | January 20, 2010 | Biotech News - PR Newswire |
| BIO Ventures for Global Health Chosen as Administrator of Intellectual Property Pool Involving GSK and Alnylam as Participants | January 20, 2010 | FDA News - Business Wire |
| Alnylam and Collaborators Present Data from Multiple Pre-Clinical and Clinical Programs at RNAi Keystone Symposium | January 19, 2010 | Pharma News - Business Wire |
| Alnylam and Collaborators Discover Additional Class of Novel Lipid Nanoparticles with Markedly Improved In Vivo Potency for RNAi Therapeutics | January 19, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals's Kreutzer-Limmer I Patent Upheld in German Opposition Proceedings | January 15, 2010 | BioSpace - Breaking News |
| Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months | January 11, 2010 | Pharma News - Business Wire |
| Alnylam Maps Out First Steps in ‘RNA Decade’ | January 11, 2010 | Xconomy Life Sciences |
| Alnylam and Collaborators Discover Key Mechanism for Delivery of RNAi Therapeutics | January 08, 2010 | Biotech News - Business Wire |
| Alnylam to Webcast Presentation at the 28th Annual J.P. Morgan Healthcare Conference | January 06, 2010 | Pharma News - Business Wire |
| Alnylam Pharmaceuticals Gets Milestone From Roche | January 06, 2010 | BioSpace |
| Alnylam Receives Milestone Payment from Roche Related to Advancement of RNAi Therapeutics | January 06, 2010 | Clinical Trials - Business Wire |
| Alnylam Earns Roche RNAi Milestone | January 06, 2010 | Contract Pharma |
| Alnylam Gets Milestone From Roche | January 06, 2010 | Xconomy Life Sciences |
| Alnylam Pharmaceuticals and Collaborators at Massachusetts Institute of Technology (MIT) Report New Pre-clinical Research on Systemic Delivery of RNAi Therapeutics | December 29, 2009 | BioSpace - Breaking News |
| Alnylam Pharmaceuticals Studying the History of Genzyme Corporation Eyes Drug to Make Big Difference for Rare Disease | December 14, 2009 | BioSpace |
| Forma Gets a $25.5M Fix, Novartis Bids Idera Adieu, Alnylam CEO Talks Strategy, & More Boston-Area Life Sciences News | December 02, 2009 | Xconomy Life Sciences |
| Hyper-Analytical “Insanity” Cripples Drug R&D, Says Alnylam CEO John Maraganore | November 30, 2009 | Xconomy Life Sciences |
| Alnylam and Collaborators at MIT Report New Pre-clinical Research on Systemic Delivery of RNAi Therapeutics | | Pharma News - Business Wire |
| Isis and Alnylam Announce Notice of Allowance for New U.S. Patent Application Broadly Covering RNAi Therapeutics | | Biotech News - Business Wire |
| Alnylam to Webcast Presentation at Piper Jaffray 21st Annual Health Care Conference | | Pharma News - Business Wire |
